Additionally, IHC analysis of vehicle and EC359 treated tissues using Ki-67 and GPX4 antibodies revealed decreased proliferation and reduced GPX4 levels in EC359-treated tumor tissues (Figure 5D–F). This evidence concerns the gene GPX4 and neoplasm.